About JCIC

The Japanese Society of Congenital Interventional Cardiology (JCIC), formerly known as JPIC, was established in 1990 as an academic study group focused on transcatheter therapy for congenital heart disease. In April 2017, the society was formally registered as a general incorporated association. In January 2020, the society officially changed its name from JPIC to JCIC. JCIC is a subcommittee of the Japanese Society of Pediatric Cardiology and Cardiac Surgery (JSPCCS), dedicated to the advancement of interventional therapy for congenital and pediatric-onset heart diseases in Japan.

Over the years, Japan has witnessed significant development in interventional catheterization techniques for congenital heart disease, not only in terms of medical technology but also in regulatory frameworks, insurance coverage, and the establishment of a national registry. JCIC has played a pivotal role in promoting these advancements by fostering clinical research, organizing academic meetings, and enhancing training opportunities for young professionals in the field.

In addition to its core mission, JCIC actively collaborates with regulatory agencies, academic societies, and industry partners both in Japan and internationally. The society also works to expand access to safe and effective devices tailored for children, while collecting and analyzing real-world data through the JCIC Registry (JCIC-R).

JCIC is committed to continuing its efforts to improve the quality of life for children with heart disease by promoting minimally invasive, catheter-based therapies that are both safe and effective.